Roche Holding AG (RHO5) Stock Forecast & Price Target

Compare

67 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

RHO5 Analyst Ratings

Hold

5 Buy

3 Hold

4 Sell

Based on 12 analysts giving stock ratings to

Roche

Holding AG

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

RHO5 Stock 12 Month Forecast

Average Price Target

€295.17

▲(8.38% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Roche Holding AG in the last 3 months. The average price target is €295.17 with a high forecast of €367.28 and a low forecast of €244.85. The average price target represents a 8.38% change from the last price of €272.35.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"234":"€234","301":"€301","368":"€368","267.5":"€267.5","334.5":"€334.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":367.2756403404,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€367.28</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":295.1742939638,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€295.17</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":244.8504268936,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€244.85</span>\n  </div></div>","useHTML":true}}],"tickPositions":[234,267.5,301,334.5,368],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,270,277.4827415646462,284.9654831292923,292.44822469393847,299.9309662585846,307.41370782323077,314.89644938787694,322.37919095252306,329.86193251716924,337.34467408181536,344.82741564646153,352.3101572111077,359.7928987757538,{"y":367.2756403404,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,270,271.93648415106156,273.87296830212307,275.80945245318463,277.74593660424614,279.6824207553077,281.6189049063692,283.5553890574308,285.4918732084923,287.42835735955384,289.36484151061535,291.3013256616769,293.2378098127384,{"y":295.1742939638,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,270,268.06541745335386,266.1308349067077,264.1962523600615,262.2616698134154,260.32708726676924,258.3925047201231,256.4579221734769,254.52333962683076,252.58875708018462,250.65417453353845,248.7195919868923,246.78500944024614,{"y":244.8504268936,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":235.013,"date":1722470400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":235.013,"date":1725148800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":235.013,"date":1727740800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":235.013,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 17</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":235.013,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":235.013,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":235.013,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 19</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":235.013,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":245.2,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":245.2,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":283.6,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":278.05,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":270,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€367.28

Average Price Target€295.17

Lowest Price Target€244.85

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Sarita Kapila

Morgan Stanley

€303.17→€259.71

Sell

-4.64%

Downside

Downgraded

08/08/25

Roche Holding AG Faces Growth Challenges Amidst Competition and Regulatory Risks, Downgraded to Underweight

Luisa Hector

Berenberg Bank

€307.41

Hold

12.87%

Upside

Reiterated

08/07/25

Berenberg Bank Sticks to Its Hold Rating for Roche Holding AG (RHHVF)

Florent Cespedes

Bernstein

€365.71

Buy

34.28%

Upside

Reiterated

08/01/25

Bernstein Keeps Their Buy Rating on Roche Holding AG (RHHVF)

Veda Pharmyne

TR | OpenAI - 4o

€305.29→€306.35

Buy

12.48%

Upside

Reiterated

07/30/25

AI Generated ArticleAI Generated Article

Matthew Weston

UBS

€332.85

Buy

22.21%

Upside

Reiterated

07/28/25

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (NASDAQ: SRPT) and Roche Holding AG (Other OTC: RHHVF)

Richard Vosser

J.P. Morgan

€233.21→€243.81

Sell

-10.48%

Downside

Reiterated

07/28/25

J.P. Morgan Keeps Their Sell Rating on Roche Holding AG (RHHVF)

Emily Field

Barclays

€291.51

Hold

7.03%

Upside

Reiterated

07/28/25

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Lonza Group (Other OTC: LZAGY)

James Quigley

Goldman Sachs

€260.77→€256.53

Sell

-5.81%

Downside

Reiterated

07/28/25

Goldman Sachs Reaffirms Their Sell Rating on Roche Holding AG (RHHVF)

Elmar Kraus

DZ BANK AG

―

Buy

―

Reiterated

07/25/25

DZ BANK AG Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)

Benjamin Jackson CFA

Jefferies

€286.21

Hold

5.09%

Upside

Reiterated

07/24/25

Analysts Conflicted on These Healthcare Names: Roche Holding AG (Other OTC: RHHVF) and Thermo Fisher (NYSE: TMO)

David Evans

Kepler Capital

€333.91

Buy

22.60%

Upside

Reiterated

07/24/25

Kepler Capital Sticks to Its Buy Rating for Roche Holding AG (RHHVF)

Emmanuel Papadakis

Deutsche Bank

€249.11

Sell

-8.53%

Downside

Reiterated

07/22/25

Deutsche Bank Reaffirms Their Sell Rating on Roche Holding AG (RHHVF)

Rajesh Kumar

HSBC

€358.29→€312.71

Hold

14.82%

Upside

Downgraded

04/28/25

Roche downgraded to Hold from Buy at HSBCRoche downgraded to Hold from Buy at HSBC

Peter Verdult

Exane BNP Paribas

€318.01

Buy

16.77%

Upside

Initiated

04/16/25

BNP Paribas Exane Starts Roche Holding (ROG:SW) (RHHBY) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Roche Holding (ROG:SW) (OTC: RHHBY) with a Outperform rating and a price target of CHF300.00.

Hans Engel

Erste Group

―

Hold

―

Downgraded

11/05/24

Erste Group Downgrades Roche Holding (ROG:SW) (RHHBY) to HoldErste Group analyst Hans Engel downgraded Roche Holding (ROG:SW) (OTC: RHHBY) from Buy to Hold.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Sarita Kapila

Morgan Stanley

€303.17→€259.71

Sell

-4.64%

Downside

Downgraded

08/08/25

Roche Holding AG Faces Growth Challenges Amidst Competition and Regulatory Risks, Downgraded to Underweight

Luisa Hector

Berenberg Bank

€307.41

Hold

12.87%

Upside

Reiterated

08/07/25

Berenberg Bank Sticks to Its Hold Rating for Roche Holding AG (RHHVF)

Florent Cespedes

Bernstein

€365.71

Buy

34.28%

Upside

Reiterated

08/01/25

Bernstein Keeps Their Buy Rating on Roche Holding AG (RHHVF)

Veda Pharmyne

TR | OpenAI - 4o

€305.29→€306.35

Buy

12.48%

Upside

Reiterated

07/30/25

AI Generated ArticleAI Generated Article

Matthew Weston

UBS

€332.85

Buy

22.21%

Upside

Reiterated

07/28/25

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (NASDAQ: SRPT) and Roche Holding AG (Other OTC: RHHVF)

Richard Vosser

J.P. Morgan

€233.21→€243.81

Sell

-10.48%

Downside

Reiterated

07/28/25

J.P. Morgan Keeps Their Sell Rating on Roche Holding AG (RHHVF)

Emily Field

Barclays

€291.51

Hold

7.03%

Upside

Reiterated

07/28/25

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Lonza Group (Other OTC: LZAGY)

James Quigley

Goldman Sachs

€260.77→€256.53

Sell

-5.81%

Downside

Reiterated

07/28/25

Goldman Sachs Reaffirms Their Sell Rating on Roche Holding AG (RHHVF)

Elmar Kraus

DZ BANK AG

―

Buy

―

Reiterated

07/25/25

DZ BANK AG Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)

Benjamin Jackson CFA

Jefferies

€286.21

Hold

5.09%

Upside

Reiterated

07/24/25

Analysts Conflicted on These Healthcare Names: Roche Holding AG (Other OTC: RHHVF) and Thermo Fisher (NYSE: TMO)

David Evans

Kepler Capital

€333.91

Buy

22.60%

Upside

Reiterated

07/24/25

Kepler Capital Sticks to Its Buy Rating for Roche Holding AG (RHHVF)

Emmanuel Papadakis

Deutsche Bank

€249.11

Sell

-8.53%

Downside

Reiterated

07/22/25

Deutsche Bank Reaffirms Their Sell Rating on Roche Holding AG (RHHVF)

Rajesh Kumar

HSBC

€358.29→€312.71

Hold

14.82%

Upside

Downgraded

04/28/25

Roche downgraded to Hold from Buy at HSBCRoche downgraded to Hold from Buy at HSBC

Peter Verdult

Exane BNP Paribas

€318.01

Buy

16.77%

Upside

Initiated

04/16/25

Hans Engel

Erste Group

―

Hold

―

Downgraded

11/05/24

Erste Group Downgrades Roche Holding (ROG:SW) (RHHBY) to HoldErste Group analyst Hans Engel downgraded Roche Holding (ROG:SW) (OTC: RHHBY) from Buy to Hold.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Roche Holding AG

1 Month

xxx

Success Rate

33/57 ratings generated profit

Average Return

+1.13%

reiterated a xxx

rating 30 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 57.89% of your transactions generating a profit, with an average return of +1.13% per trade.

3 Months

xxx

Success Rate

36/50 ratings generated profit

Average Return

+1.58%

reiterated a xxx

rating 24 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 72.00% of your transactions generating a profit, with an average return of +1.58% per trade.

1 Year

Richard VosserJ.P. Morgan

Success Rate

31/50 ratings generated profit

Average Return

+2.44%

reiterated a sell rating 24 days ago

Copying Richard Vosser's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +2.44% per trade.

2 Years

xxx

Success Rate

34/57 ratings generated profit

Average Return

+5.36%

reiterated a xxx

rating 30 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 59.65% of your transactions generating a profit, with an average return of +5.36% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RHO5 Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, RHO5 has received 17 Buy Ratings, 8 Hold Ratings, and 14 Sell Ratings. RHO5 average Analyst price target in the past 3 months is 295.17.

Each month's total comprises the sum of three months' worth of ratings.

RHO5 Financial Forecast

RHO5 Earnings Forecast

Next quarter’s earnings estimate for RHO5 is €9.83 with a range of €9.01 to €11.31. The previous quarter’s EPS was €11.75. RHO5 beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.19% of the time in the same period. In the last calendar year RHO5 has Outperformed its overall industry.

RHO5 Sales Forecast

Next quarter’s sales forecast for RHO5 is €33.35B with a range of €32.86B to €33.87B. The previous quarter’s sales results were €32.80B. RHO5 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 46.87% of the time in the same period. In the last calendar year RHO5 has Outperformed its overall industry.

RHO5 Stock Forecast FAQ

What is DE:RHO5’s average 12-month price target, according to analysts?

Based on analyst ratings, Roche Holding’s 12-month average price target is 295.17.

What is DE:RHO5’s upside potential, based on the analysts’ average price target?

Roche Holding has 8.38% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Roche Holding a Buy, Sell or Hold?

Roche Holding has a consensus rating of Hold, which is based on 5 buy ratings, 3 hold ratings and 4 sell ratings.

What is Roche Holding’s share price target?

The average share price target for Roche Holding is 295.17. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €367.28 ,and the lowest forecast is €244.85. The average share price target represents 8.38% Increase from the current price of €272.35.

What do analysts say about Roche Holding?

Roche Holding’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of Roche Holding?

To buy shares of DE:RHO5, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Roche Holding AG (RHO5) Stock Forecast & Price Target

RHO5 Analyst Ratings

RHO5 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Roche Holding AG

RHO5 Analyst Recommendation Trends

RHO5 Financial Forecast

RHO5 Earnings Forecast

RHO5 Sales Forecast

RHO5 Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts